SOC-0150

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSOC-0150
Drug Alias NameSOC-0150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals scavengers
TargetsFree radicals
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScotia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScotia
Active IndicationsN/A
Inactive IndicationsDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A